AREV Life Sciences Global Corp
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AREVF research report →
About the company
AREV Life Sciences Global Corp. operates as an early-stage life science discovery company in Canada. It is involved in the extraction of compounds for consumption and topical use; clinical nutrition business; and Medicine Merchant, a technology platform.
- CEO
- Michael C. Withrow
- IPO
- 2019
- Employees
- 19,534
- HQ
- Coquitlam, BC, CA
Price Chart
- Market Cap
- $15.88K
- P/E
- -1.87
- P/S
- 57.79
- P/B
- -2.84
- EV/EBITDA
- -2.18
- Div Yield
- 0.00%
- Gross Margin
- -155.72%
- Op Margin
- -2839.86%
- Net Margin
- -2940.37%
- ROE
- 276.09%
- ROIC
- 150.98%
- Revenue
- $49.11K · -80.74%
- Net Income
- $-1,444,106 · -45.82%
- EPS
- $-0.05 · -32.96%
- Op Income
- $-1,388,788
- FCF YoY
- 75.29%
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 4.81
- Avg Volume
- 6.60K
Get TickerSpark's AI analysis on AREVF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our AREVF coverage
Recent articles, reports, and earnings notes.
No research on AREVF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AREVF report →Similar companies
Peers in the same neighborhood.